194 related articles for article (PubMed ID: 19320189)
1. Progression of skin lesions from normal skin to squamous cell carcinoma.
Krouse RS; Alberts DS; Prasad AR; Yozwiak M; Bartels HG; Liu Y; Bartels PH
Anal Quant Cytol Histol; 2009 Feb; 31(1):17-25. PubMed ID: 19320189
[TBL] [Abstract][Full Text] [Related]
2. Karyometry of nuclei from actinic keratosis and squamous cell cancer of the skin.
Ranger-Moore J; Bozzo P; Alberts D; Einspahr J; Liu Y; Thompson D; Stratton S; Stratton MS; Bartels P
Anal Quant Cytol Histol; 2003 Dec; 25(6):353-61. PubMed ID: 14714302
[TBL] [Abstract][Full Text] [Related]
3. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.
Feldman SR; Fleischer AB
Cutis; 2011 Apr; 87(4):201-7. PubMed ID: 21644496
[TBL] [Abstract][Full Text] [Related]
4. Karyometric analysis of actinic damage in unexposed and sun-exposed skin and in actinic keratoses in untreated individuals.
Ranger-Moore J; Bartels PH; Bozzo P; Einspahr J; Liu Y; Saboda K; Alberts DS
Anal Quant Cytol Histol; 2004 Jun; 26(3):155-65. PubMed ID: 15218692
[TBL] [Abstract][Full Text] [Related]
5. [Beyond actinic keratoses: Field cancerization of the skin].
Reygagne P; Rostain G
Ann Dermatol Venereol; 2018 Oct; 145(10):587-592. PubMed ID: 30243819
[TBL] [Abstract][Full Text] [Related]
6. Nuclear morphometry in solar keratosis.
Bozzo PD; Vaught LC; Alberts DS; Thompson D; Bartels PH
Anal Quant Cytol Histol; 1998 Feb; 20(1):21-8. PubMed ID: 9513688
[TBL] [Abstract][Full Text] [Related]
7. Contribution to characterization of skin field cancerization activity: morphometric, chromatin texture, proliferation, and apoptosis aspects.
Miola AC; Castilho MA; Schmitt JV; Marques MEA; Miot HA
An Bras Dermatol; 2019; 94(6):698-703. PubMed ID: 31789247
[TBL] [Abstract][Full Text] [Related]
8. Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression.
Padilla RS; Sebastian S; Jiang Z; Nindl I; Larson R
Arch Dermatol; 2010 Mar; 146(3):288-93. PubMed ID: 20231500
[TBL] [Abstract][Full Text] [Related]
9. High-definition optical coherence tomography algorithm for the discrimination of actinic keratosis from normal skin and from squamous cell carcinoma.
Boone MA; Marneffe A; Suppa M; Miyamoto M; Alarcon I; Hofmann-Wellenhof R; Malvehy J; Pellacani G; Del Marmol V
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1606-15. PubMed ID: 25656269
[TBL] [Abstract][Full Text] [Related]
10. A new algorithm for the discrimination of actinic keratosis from normal skin and squamous cell carcinoma based on in vivo analysis of optical properties by high-definition optical coherence tomography.
Boone MA; Suppa M; Marneffe A; Miyamoto M; Jemec GB; Del Marmol V
J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):1714-1725. PubMed ID: 27311752
[TBL] [Abstract][Full Text] [Related]
11. The importance of early diagnosis and treatment of actinic keratosis.
Rigel DS; Stein Gold LF
J Am Acad Dermatol; 2013 Jan; 68(1 Suppl 1):S20-7. PubMed ID: 23228303
[TBL] [Abstract][Full Text] [Related]
12. Significance of cyclooxygenase 2, EZH-2 polycomb group and p53 expression in actinic keratosis and squamous cell carcinomas of the skin.
Athanassiadou AM; Lazaris AC; Patsouris E; Tsipis A; Chelidonis G; Aroni K
Am J Dermatopathol; 2013 Jun; 35(4):425-31. PubMed ID: 23095338
[TBL] [Abstract][Full Text] [Related]
13. Actinic damage in histopathologically normal skin.
Bartels PH; Krouse RS; Prasad AR; Yozwiak M; Liu Y; Bartels HG; Alberts DS
Anal Quant Cytol Histol; 2008 Dec; 30(6):316-22. PubMed ID: 19160696
[TBL] [Abstract][Full Text] [Related]
14. Frequency of pre-existing actinic keratosis in cutaneous squamous cell carcinoma.
Mittelbronn MA; Mullins DL; Ramos-Caro FA; Flowers FP
Int J Dermatol; 1998 Sep; 37(9):677-81. PubMed ID: 9762818
[TBL] [Abstract][Full Text] [Related]
15. Validation of a diagnostic algorithm for the discrimination of actinic keratosis from normal skin and squamous cell carcinoma by means of high-definition optical coherence tomography.
Marneffe A; Suppa M; Miyamoto M; Del Marmol V; Boone M
Exp Dermatol; 2016 Sep; 25(9):684-7. PubMed ID: 27095632
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility and expression of skin biomarkers in sun-damaged skin and actinic keratoses.
Einspahr JG; Xu MJ; Warneke J; Saboda K; Ranger-Moore J; Bozzo P; Duckett L; Goldman R; Lin P; Buckmeier J; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1841-8. PubMed ID: 17021352
[TBL] [Abstract][Full Text] [Related]
17. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
18. Actinic keratosis and squamous cell carcinoma: clinical and pathological features.
Filosa A; Filosa G
G Ital Dermatol Venereol; 2015 Aug; 150(4):379-84. PubMed ID: 26099352
[TBL] [Abstract][Full Text] [Related]
19. Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin.
Einspahr J; Alberts DS; Aickin M; Welch K; Bozzo P; Grogan T; Nelson M
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):583-7. PubMed ID: 9264270
[TBL] [Abstract][Full Text] [Related]
20. Current therapies for actinic keratosis.
Dianzani C; Conforti C; Giuffrida R; Corneli P; di Meo N; Farinazzo E; Moret A; Magaton Rizzi G; Zalaudek I
Int J Dermatol; 2020 Jun; 59(6):677-684. PubMed ID: 32012240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
